Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P960016/S093

Livewire TC XLS

St Jude Medical · Decision date Jan 15, 2026

FDA DECISIONP960016/S093

What did the FDA decide?

FDA records P960016/S093 as a supplement to PMA P960016, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Jan 15, 2026.

FDA approval order statement

an alternate vapor degreaser which is used as a processing aid to remove metalworking cutting fluid on patient-contacting tip electrodes and electrode rings during manufacturing
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Jan 15, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P960016/S093
Regulatory pathway
PMA supplement
Product code
LPB
Decision code
OK30
Decision date
Jan 15, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Cardiac ablation percutaneous catheter.

Product code
LPB
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P960016/S093 received

    Application receipt date recorded by FDA.

  2. P960016/S093 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P960016. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P960016

Product / regulatory recordCompanyPathwayDecision dateSource
Ampere GeneratorP960016/S094
St Jude MedicalPMA supplementAug 7, 2026FDA

Explore the linked device profile

Other records with product code LPB

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

St Jude Medical

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
14900 Minnetonka Ind Rd., Minnetonka, MN, 55345

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records